Skip to main content

Table 4 Clearance reduction, artesunate/amodiaquine groups

From: Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009

Country site

Parasitaemia, geometric mean

N

Parasite reduction ratio (individual data)

  

d1/d0

d2/d0

d3/d0

d7/d0

Burkina faso - Nanoro 2008

21,185

295

97.8%

100.0%

100.0%

100.0%

Cameroon 2006

24,129

110

97.0%

100.0%

100.0%

100.0%

Gabon - Fougamou 2008

21,117

80

98.6%

100.0%

100.0%

100.0%

Gabon 1999

20,867

108

98.2%

100.0%

100.0%

100.0%

Kenya 1999

30,040

199

94.5%

99.9%

100.0%

100.0%

Kenya 2009

12,193

54

99.2%

100.0%

100.0%

100.0%

Madagascar 2006

9,648

119

98.9%

100.0%

100.0%

100.0%

Mali Bougoula 2006

23,744

135

93.8%

99.9%

100.0%

100.0%

Mozambique - Manhica 2008

35,924

210

77.1%

99.8%

100.0%

100.0%

Nigeria - Afokang 2008

20,326

92

96.3%

99.7%

100.0%

100.0%

Nigeria - Pamol 2008

17,329

82

97.9%

99.8%

100.0%

100.0%

Senegal 1999

41,753

160

89.5%

99.8%

100.0%

100.0%

Senegal 2006

20,201

264

91.4%

99.7%

100.0%

100.0%

Uganda - Mbarara 2008

27,262

160

98.4%

100.0%

100.0%

100.0%

Zambia - Ndola 2008

35,887

85

91.9%

100.0%

100.0%

100.0%

Zanzibar Kivunge 2002

20,625

148

95.7%

100.0%

100.0%

100.0%

Zanzibar Micheweni 2002

18,236

54

95.2%

99.7%

100.0%

100.0%

Total

23,596

2355

93.9%

99.9%

100.0%

100.0%